-
IIFL Finance
682.40 704.90(%) -
NSE
2,113.70 2,134.00(%) -
Coforge
2,060.00 2,127.30(%) -
SBI
1,142.00 1,234.80(%) -
Reliance Industries
1,354.00 1,152.30(%) -
Billionbrains
222.40 142.05(%) -
Urban Company
173.90 183.65(%) -
Eternal
365.10 212.55(%) -
Cummins India
3,968.00 3,883.30(%) -
ITC
298.00 410.95(%) -
Bharat Forge
1,683.00 1,328.15(%) -
V2 Retail
122.70 122.70(%) -
Greenlam Industr
231.55 280.60(%) -
ICICI Bank
1,610.00 1,616.70(%) -
Axis Bank
1,356.80 1,150.50(%) -
Polycab India
7,294.50 6,660.50(%) -
Adani Energy Sol
1,460.00 804.70(%) -
Lalithaa Jewel
314.20 240.30(%) -
Bajaj Finance
1,089.55 788.40(%) -
Tata Motors
436.00 308.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Senores Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations
- Indian Private
- BSE Code : 93477.0
- ISIN : INE0RB801010
-
Today’s Low
1,083.00 -
Today’s High
1,145.70
-
Open
1,138.70 -
Perv Close
1,138.70 -
52W Low
706.00 -
52W High
1,599.00
Key Indicators
-
P/E(TTM)
252.81
-
Mar.Cap (₹Cr.)
5,031.82
-
Div & Yield %
0.00
-
Book Value(₹)
164.73
-
Debt-Equity Ratio
-4.05
-
AGM Date
18-Nov-2026
-
EPS
4.32
-
P/E Ratio
252.81
Financials Ratios
-
Debt-Equity Ratio
1.28
-
Mar.Cap (₹Cr.)
5,031.82
-
RONW (%)
26.19
-
ROCE (%)
12.04
Score Board
-
Equity (₹ in Cr.)
46.05
-
BV (₹)
164.70
-
Sales( ₹ in Cr.)
106.09
-
NP (in Cr.)
20.25
-
NP Var(%)
449.0
-
Div%
0.0
-
CPS (₹)
7.30
-
EPS (₹)
4.40
-
Traded Value (₹ in Lakhs)
5,029.74
-
52 Week High
1,599.00
-
52 Week Low
706.00
-
Price BSE
1092.0
-
Price NSE
1,093.00
-
Market Capital( in Cr.)
5,029.74
-
P/C Ratio
150.20
-
P/E Ratio
248.30
-
Price Vs.BV
4.40
-
30-Oct-2026( 10:34)
Results - Announcements - Senor... - <p>Senores Pharmaceuticals Ltd...
-
29-Oct-2026( 06:58)
Corporate News - Senor... - <p>Senores Pharmaceuticals Lim...
-
29-Oct-2026( 05:51)
Corporate News - Senor... - <p>Senores Pharmaceuticals Lim...
-
21-Oct-2026( 07:04)
Results - Announcements - Senor... - <p>Senores Pharmaceuticals Ltd...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 106.09 | 38.54 | 34.01 | 12.38 | 13.54 | 7.91 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 106.09 | 38.54 | 34.01 | 12.38 | 13.54 | 7.91 |
| Other Income | 66.35 | 21.99 | 6.84 | 6.79 | 0.94 | 0.15 |
| Stock Adjustments | 0.30 | 4.10 | 0.39 | 0.48 | 2.40 | -0.05 |
| Total Income | 172.74 | 64.63 | 41.24 | 19.65 | 16.88 | 8.01 |
| EXPENDITURE : | ||||||
| Raw Materials | 54.97 | 21.93 | 14.08 | 6.35 | 10.60 | 3.94 |
| Power and Fuel Cost | 2.10 | 0.44 | 0.31 | 0.00 | 0.00 | 0.03 |
| Employee Cost | 38.78 | 18.25 | 9.35 | 5.02 | 2.86 | 1.63 |
| Other Manufacturing Expenses | 13.39 | 2.06 | 6.89 | 0.05 | 0.04 | 0.76 |
| Selling and Administration Expenses | 15.02 | 7.19 | 3.79 | 2.96 | 1.28 | 0.35 |
| Miscellaneous Expenses | 0.81 | 0.05 | 0.04 | 0.26 | 0.00 | 0.14 |
| Employee Benefit Expenses | 38.78 | 18.25 | 9.35 | 5.02 | 2.86 | 1.63 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 125.07 | 49.92 | 34.46 | 14.65 | 14.79 | 6.84 |
| Operating Profit | 47.67 | 14.71 | 6.78 | 5.01 | 2.10 | 1.17 |
| Interest | 6.98 | 6.52 | 2.71 | 2.14 | 0.56 | 0.20 |
| Gross Profit | 40.69 | 8.19 | 4.07 | 2.87 | 1.54 | 0.97 |
| Depreciation | 13.23 | 3.08 | 2.04 | 0.93 | 0.71 | 0.57 |
| Profit Before Tax | 27.46 | 5.11 | 2.03 | 1.94 | 0.83 | 0.40 |
| Current Tax | 8.45 | 1.45 | 1.36 | 0.35 | 0.17 | 0.01 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -1.24 | -0.03 | -0.14 | 0.39 | -0.02 | -0.45 |
| Reported Net Profit | 20.25 | 3.69 | 0.81 | 1.20 | 0.68 | 0.84 |
| Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Net Profit | 20.25 | 3.69 | 0.81 | 1.20 | 0.68 | 0.84 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| P & L Balance brought forward | 7.07 | 3.39 | 2.57 | 1.37 | 0.69 | 0.34 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 27.32 | 7.08 | 3.39 | 2.57 | 1.37 | 1.18 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 4.40 | 0.80 | 0.27 | 1.22 | 0.78 | 2.20 |
| Earnings Per Share(Adj)-Unit Curr | 4.40 | 0.80 | - | - | - | - |
| Book Value | 162.78 | 153.74 | 55.10 | 39.66 | 38.54 | 24.91 |
| Book Value(Adj)-Unit Curr | 162.78 | 153.74 | - | - | - | - |
